121 related articles for article (PubMed ID: 15753605)
1. Molecular analysis of pancreatic juice: a helpful tool to differentiate benign and malignant pancreatic tumors?
Teich N; Mossner J
Dig Dis; 2004; 22(3):235-8. PubMed ID: 15753605
[TBL] [Abstract][Full Text] [Related]
2. Genetic diagnosis of pancreatic cancer.
Mizumoto K; Tanaka M
J Hepatobiliary Pancreat Surg; 2002; 9(1):39-44. PubMed ID: 12021896
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
[TBL] [Abstract][Full Text] [Related]
5. [Geneteic diagnosis for pancreatic tumors].
Watanabe H; Ohtsubo K; Yamaguchi Y; Sawabu N
Nihon Rinsho; 2006 Jan; 64 Suppl 1():148-52. PubMed ID: 16457239
[No Abstract] [Full Text] [Related]
6. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas.
Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M
Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Thosani N; Dasari CS; Bhutani MS; Raimondo M; Guha S
Pancreas; 2010 Nov; 39(8):1129-33. PubMed ID: 20881900
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
10. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N
Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750
[TBL] [Abstract][Full Text] [Related]
11. [K-ras mutation in pancreatic juice from patients with pancreatic carcinoma].
Gong X; Chen Y; Chen Y; Lu X
Zhonghua Nei Ke Za Zhi; 1999 Oct; 38(10):673-6. PubMed ID: 11798705
[TBL] [Abstract][Full Text] [Related]
12. [An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].
Lu X; Xu T; Qian J
Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1050-3. PubMed ID: 11758254
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
[TBL] [Abstract][Full Text] [Related]
15. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
Sawabu N; Watanabe H; Yamaguchi Y; Okai T
Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
[TBL] [Abstract][Full Text] [Related]
17. Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions.
Klump B; Hsieh CJ; Nehls O; Dette S; Holzmann K; Kiesslich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
Br J Cancer; 2003 Jan; 88(2):217-22. PubMed ID: 12610506
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of chronic pancreatitis patients with K-ras mutation in the pancreatic juice.
Kamisawa T; Takuma K; Tabata T; Egawa N; Yamaguchi T
Hepatogastroenterology; 2011; 58(105):174-6. PubMed ID: 21510309
[TBL] [Abstract][Full Text] [Related]
19. [Molecular diagnosis of pancreatic cancer].
Sugano K
Nihon Geka Gakkai Zasshi; 1997 Jul; 98(7):597-603. PubMed ID: 9276865
[TBL] [Abstract][Full Text] [Related]
20. [Alteration of the K-ras and p16/CDKN2 gene in endocrine pancreatic carcinomas].
Shirahama S; Matsuyoshi J; Yamamoto S; Tsukada Y
Nihon Rinsho; 2004 May; 62(5):889-93. PubMed ID: 15148814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]